🏅 FDA Orphan Designation

Triptodur

triptorelin pamoate

Manufacturer: Arbor Pharmaceuticals, LLC

Indicated for:

Rare central precocious pubertyOrphan

FDA-Approved Indications (1)

Rare central precocious pubertyOrphan Designation

Treatment of pediatric patients 2 years of age and older with central precocious puberty

Indications & Usage

1 INDICATIONS AND USAGE TRIPTODUR is indicated for the treatment of pediatric patients 2 years of age and older with central precocious puberty (CPP). TRIPTODUR is a gonadotropin releasing hormone (GnRH) agonist indicated for the treatment of pediatric patients 2 years and older with central precocious puberty. ( 1 )

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.